Klotho-FG is a recombinant form of the Klotho protein, studied for its role in healthy aging, brain and kidney function, and metabolic regulation. It works by enhancing FGF23 signaling and modulating oxidative stress, calcium balance, and cellular repair pathways.
Refill Program Details:
One refill every every month for 12 months
Benefits
May support brain function, cognitive clarity, and neural repair
May promote longevity, skin regeneration, and cellular health
May enhance kidney, cardiovascular, and calcium-phosphate balance
May reduce systemic inflammation and protect against neurodegeneration
May boost energy, libido, and reproductive health
Dosing
Administer 25 units (0.25mL) each dose
Three times per week (M,W,F)
How to Use
Duration: 12 months
3 months on, 30 day break, 3 months on, 30 day break, 6 months on
Reconstitute: add 5mL of bacteriostatic water
Intramuscular or subcutaneous injection
MOA
Klotho-FG Axis and FGF Signaling
FGF23 (with α-Klotho) – Regulation of Phosphate and Calcium Metabolism
Produced by bone osteocytes and acts on the kidneys
Requires α-Klotho to bind to FGFRs and suppress renal phosphate reabsorption and vitamin D synthesis
FGF19 and FGF21 (with β-Klotho) – Metabolic Regulation
FGF19: Regulates bile acid metabolism, reduces bile acid synthesis, increases glycogen storage, and improves insulin sensitivity
FGF21: Enhances glucose uptake, increases lipolysis and fatty acid oxidation, and promotes thermogenesis
Binding and Signal Transduction
Klotho as a Co-Receptor
Klotho proteins increase FGF binding affinity to FGFRs
Forms FGFR-Klotho-FGF complex that stabilizes receptor-ligand interaction
FGFR Activation
Ligand binding induces FGFR dimerization and autophosphorylation
Activates intracellular pathways:
MAPK/ERK – regulates gene expression for metabolism and growth
PI3K/AKT – promotes cellular survival and energy metabolism
STAT – regulates inflammatory response and cell proliferation
Biological Effects
Phosphate and Calcium Regulation (FGF23 + α-Klotho)
Decreases renal phosphate reabsorption by downregulating Na+/Pi cotransporters
Suppresses 1,25-dihydroxyvitamin D production, reducing calcium and phosphate absorption in the gut
Metabolic Regulation (FGF19/FGF21 + β-Klotho)
FGF19: Inhibits bile acid synthesis, increases glycogen storage, reduces gluconeogenesis
FGF21: Enhances glucose uptake, stimulates fatty acid oxidation and thermogenesis
More Information
Disclaimer: For Research Purposes Only – All products on this site are for Research and Development use only. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. Celia Health is a supplier of research-use chemicals manufactured in a CGMP facility in the US. Celia Health is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act.
This product requires a prescription. After purchasing, you will receive instructions to schedule and complete your intake exam before your order can be fulfilled. Prescriptions are valid for one calendar year.